About: Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2003

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2003 (uk) im Mai 2003 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en 2003 (fr) artículu científicu espublizáu en mayu de 2003 (ast) scientific article published on 01 May 2003 (en)
publication date	wds:Q73483944-A945A516-93E0-42EF-A7DE-5A2DD3C06E92
publication date	2003-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73483944-3FB5AB36-4461-46CB-A2F2-842150246F19
language of work or name	English
cites work	wds:Q73483944-15F3AD5D-7499-4439-8696-EEFA480A3712 wds:Q73483944-39F570B6-A7F4-448D-A2E4-9B73111AB7BE wds:Q73483944-77E77389-7666-4185-B594-B7D7C2347083 wds:Q73483944-9B2943CB-C217-4037-BF93-3399C54D5A1E wds:Q73483944-C0704140-FC18-494B-9B0B-D5F53A415111
cites work	Cholera Manson Lecture. Meningococcal meningitis in Africa. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England Introducing GAVI and the Global Fund for Children's Vaccines Vaccines for the developing world: current status and future directions
author name string	wds:Q73483944-130664D5-2A12-44AE-8592-AE24011572C6 wds:Q73483944-2722C617-C029-41C1-B995-60BECADD0D2D wds:Q73483944-2C7FB120-F893-431C-B501-DE89197829F0 wds:Q73483944-8985D6B4-1EF4-4CAD-AD38-908E72B19B8F wds:Q73483944-B03AF26D-8E97-4BD3-B9A8-85E0C3562CB5
author name string	Costante Ceccarini Dan M Granoff Luis Jódar F Marc LaForce Teresa Aguado
rdfs:label	Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries (en) Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries (nl)
skos:prefLabel	Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries (en) Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries (nl)
name	Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries (en) Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries (nl)
title	wds:Q73483944-F01579AA-FA57-4D10-9AAB-EB0896A819FA
title	Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries (en)
page(s)	wds:Q73483944-4A5B47F0-BEEF-4068-B259-C23D9EAF7FB8
page(s)	1902-1904
instance of	wds:Q73483944-8F3F8637-027D-499B-B148-9955F097F596
instance of	scholarly article
PubMed ID	wds:Q73483944-B86F492F-AD87-41EB-9846-B8A51BB3BE1A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12788589
PubMed ID	12788589
published in	wds:Q73483944-D7364C8C-8FC7-45C8-9A56-78B528DF604A
published in	The Lancet
issue	wds:Q73483944-F291C940-B08B-4EB9-A311-12D4478D9087
volume	wds:Q73483944-98010415-9AAD-4754-B2B6-424448F69301
issue	9372
volume	361
DOI	wds:Q73483944-1BADB959-35F3-4353-A78A-7372CA02CAA0
DOI	http://dx.doi.org/10.1016/S0140-6736(03)13494-0
DOI	10.1016/S0140-6736(03)13494-0
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73483944
is cites work of	Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa The Evolution of the Meningitis Vaccine Project From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project Prospects for vaccine prevention of meningococcal infection Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease Meningococcal disease and climate Product Development Partnerships Hit Their Stride: Lessons From Developing A Meningitis Vaccine For Africa Tiered pricing of vaccines: a win-win-win situation, not a subsidy. The Meningitis Vaccine Project Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school children Methods for identifying Neisseria meningitidis carriers: a multi-center study in the African meningitis belt The promise of conjugate vaccines for Africa Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989. Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa. Summary and Recommendations from the National Institute of Allergy and Infectious Diseases (NIAID) Workshop "Gonorrhea Vaccines: the Way Forward". Technical Development of a New Meningococcal Conjugate Vaccine Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India Developmental strategy fora new Group A meningococcal conjugate vaccine (MenAfriVacR). Ambiguous Capture: Collaborative Capitalism and the Meningitis Vaccine Project Meningococcal meningitis The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines A study of physico-chemical interactions between Haemophilus influenzae type b and meningococcus group C conjugate vaccines Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age. The epidemiology of Neisseria meningitidis meningitis in Togo during 2003-2005 Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7 An evaluation of emerging vaccines for childhood meningococcal disease Vaccination strategies for the prevention of meningococcal disease. The real cost of an affordable vaccine for meningococcus A. Portrait: coincidences, convergences and opportunities
is cites work of	wds:Q33561983-BD20E967-CC52-44F1-8594-123EEA20D6C2 wds:Q26778284-25FAEEA7-DC56-45A9-A0C6-B4BC0712BC1F wds:Q40458421-323C105D-B4D2-42DB-AB6D-816021723ACE wds:Q46758477-A7B9C82E-0B0C-44E9-8C30-997EB0DB279B

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software